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Abstract
Background: Rapid-onset obesity with hypoventilation, hypothalamic dysfunction, and autonomic dysregulation
syndrome is a rare pediatric disorder with a variable sequence of clinical presentations, undefined etiology, and
high risk of mortality. Our patient presented an unusual course of the disease accompanied by a homogenous mild
enlargement of her pituitary gland with an intact pituitary–endocrine axis which, to the best of our knowledge,
represents a new finding in rapid-onset obesity with hypoventilation, hypothalamic dysfunction, and autonomic
dysregulation syndrome.
Case presentation: We present a documented case of a 4 years and 8-month-old Syrian Arabic girl with a
distinctive course of signs and symptoms of rapid-onset obesity with hypoventilation, hypothalamic dysfunction,
and autonomic dysregulation syndrome accompanied by mature ganglioneuroma in her chest, a homogenous
mild enlargement of her pituitary gland, generalized cortical brain atrophy, and seizures. Three months after her first
marked symptoms were noted she had a sudden progression of severe respiratory distress that ended with her
death.
Conclusions: The findings of this case could increase our understanding of the pathogenetic mechanisms of rapid-
onset obesity with hypoventilation, hypothalamic dysfunction, and autonomic dysregulation, and place more
emphases on pediatricians to consider rapid-onset obesity with hypoventilation, hypothalamic dysfunction, and
autonomic dysregulation syndrome whenever early rapid onset of obesity, associated with any malfunction, is
observed in children. This knowledge could be lifesaving for children with rapid-onset obesity with hypoventilation,
hypothalamic dysfunction, and autonomic dysregulation syndrome.
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Background
Rapid-onset obesity with hypoventilation, hypothalamic
dysfunction, and autonomic dysregulation (ROHHAD) is
a rare pediatric disorder. It was first described in 1965 as
late-onset central hypoventilation with hypothalamic
dysfunction (LO-CHH) [1].
Rapid hyperphagic gain of weight in a previously normal
child after 2 years of age is the most consistent first symp-
tom of ROHHAD [2]. Respiratory signs and symptoms
may include obstructive sleep apnea, snoring, cyanosis,
and alveolar hypoventilation causing hypoxemia and
hypercarbia [3], which may cause cardiorespiratory arrest
and even sudden death before being recognized [4].
Evidence of hypothalamic dysfunction is defined by
the presence of one or more of the following findings:
rapid onset obesity, hyperprolactinemia, central
hypothyroidism, central diabetes insipidus, hypernatre-
mia/hyponatremia, failed growth hormone stimulation
test, corticotropin deficiency, or delayed or precocious
puberty [5]. Autonomic dysregulation may manifest as
altered pupil response to light, strabismus, gastrointes-
tinal dysmotility (constipation or diarrhea), thermal
Fig. 1 A growth chart showing stature and weight for age
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dysregulation (hyperthermia/hypothermia), decreased
sensation of pain, tachyarrhythmia or bradyarrhythmia,
altered sweating, or hypertension [6, 7]. Other features
in one subset of patients may include behavioral disor-
ders, developmental disorders, intellectual impairment,
and seizures which need to be closely evaluated to be
sure that episodes are not related to hypoxemia or
hypernatremia [8–10]. Approximately 35% of patients
with ROHHAD have neural crest tumors (ganglioneuro-
blastomas and ganglioneuromas) in the chest or abdo-
men at a median of 2.4 years interval following the onset
of hypothalamic dysfunction [11]. The modified
acronym ROHHAD-NET (ROHHAD-neuroendocrine
tumor) is used when a neural crest tumor is present [3].
Case presentation
Our case is a 4 years and 8-month-old Syrian Arabic girl
with a birth weight of 4 kg, who is the sixth of seven sib-
lings born to healthy consanguineous parents. She followed
normal psychomotor development and experienced no
remarkable illness until the age of 4 years and 2 months
when her parents noticed a rapid weight gain (about 1 kg
Fig. 2 A growth chart showing body mass index for age
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every 10 to 15 days) due to excessive eating (she
required six to seven big meals/day). Later, they ob-
served her to have alterations in body secretion (de-
creased tears when crying, decreased nasal discharge,
unfavorable body odor, and decreased sweating) in
addition to blue cold extremities, diarrhea alternated with
constipation, polyuria, and polydipsia. Two months after
the onset of obesity she had urinary incontinence during
night sleep. Then, significant behavioral changes devel-
oped including: mood alteration, anxiety episodes, rage at-
tacks, nervousness, and aggressive behavior, in addition to
recurrent fatigue, social withdrawal, prolonged periods of
sleep (12 hours continuously), and difficulty staying awake
during the day. These complaints grew to be a serious
concern to the family so she was admitted to Damascus
Children Hospital, endocrinal department, at the age of
4.5 years, for further investigations.
For three generations, the family history was negative
for similar presentations, obesity, or psychiatric disor-
ders. It was noteworthy that an older sister of our pa-
tient had died at the age of 12 years with a diagnosis of
acute myeloid leukemia (AML). Her sister’s malignancy
was not accompanied by any of the signs or symptoms
our patient had.
On physical examination, general obesity was noticed
without striae or altered skin pigmentation. No dys-
morphic features were observed, neither were there any
minor or major congenital malformations. Her weight
was 25 kg (above 97% percentile) while her length and
head circumference measured 110 cm (at 90% percentile)
and 52 cm respectively. Her body mass index (BMI) was
equal to 20.1 (Figs. 1 and 2).
An ophthalmic examination revealed left exotropia
with normal fundus and normal papillary response. The
performed laboratory analyses did not indicate any sig-
nificant abnormality. Her complete blood count (CBC),
blood glucose, sodium (Na), chlorine (Cl), potassium
(K), calcium (Ca), alanine aminotransferase (ALT), as-
partate aminotransferase (AST), triglycerides (TG), chol-
esterol, urine density, creatinine, and urea were all
within normal limits. Her thyroid-stimulating hormone
(TSH), free thyroxine (T4), morning cortisol, adrenocor-
ticotropic hormone (ACTH), prolactin, growth hormone
(GH), insulin-like growth factor-1 (IGF1), follicle-
stimulating hormone (FSH), and luteinizing hormone
(LH) were also within normal limits.
Her abdominal and pelvic ultrasound was normal. Her
bone age was slightly advanced and it fitted 5 to 5.5
years old. Brain magnetic resonance imaging (MRI) was
normal; it showed no cortical atrophy. A homogenous
mild enlargement of her pituitary gland was observed on
both T1-weighted and T2-weighted images with normal
hyperintense posterior lobe on T1-weighted images
(Figs. 3 and 4).
Since the endocrine function tests were normal, her
symptoms had been explained on the basis of psycho-
tropic origin, and she was discharged with anti-
psychotic medication (risperidone 1 mg orally per
day) and the recommendation to follow up at the
out-patient psychiatric clinic after 3 months of pre-
scribed treatment. After 3 months of discharge, when
she was 4 years and 8 months old, she developed dys-
pnea that worsened with exertion and during sleep,
continuous snoring, and recurrent chest pain. The re-
spiratory symptoms lasted for 5 days after which she
had two episodes of cyanosis and obstructive apnea
which lasted for 10 minutes with improvement via
oxygen mask. As a result of progressive respiratory
distress (respiratory rate 35/min, expiratory grunting,
flaring of nostrils, wheezing with prolonged expir-
ation, and remarkably loud snoring) she was readmitted
to Damascus Children Hospital, intensive care unit (ICU).
Investigations showed hypoxemia, hypercapnia, and
Fig. 3 Magnetic resonance imaging. Sagittal and coronal precontrast
T1-weighted image of the patient’s pituitary gland showing normal
anterior and posterior lobes, with homogeneous enlargement and
convex upper surface of the gland
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respiratory acidosis accompanied by radiological evidence
of a big round opacity in her right lung (Fig. 5).
She was intubated 24 hours after admission and at-
tached to a mechanical ventilator because of severe re-
spiratory distress with altered consciousness: blood gases
were pH 7.27, partial pressure of carbon dioxide
(PaCO2) 79 mmHg, partial pressure of oxygen (PaO2) 38
mmHg, and oxygen saturation 79%. Her laboratory re-
sults were within normal limits except for elevated
values of Na (up to 162) and C-reactive protein (77 mg/
L). During this admission, her weight was recorded as
40 kg (>97th percentile).
A chest computed tomography (CT) scan demon-
strated a 6 cm round mass filling most of her right lung
and pushing her heart and mediastinum to the left with
infiltration and consolidation of the right lower lobe of
her right lung (Fig. 6).
Subsequently, when her health stabilized, a complete
resection was performed of a 10×10 cm solid round
mass from the posterior wall of her chest. It was a ma-
ture ganglioneuroma (Fig. 7).
Her unexplained rapid gain of weight and the presence
of chest ganglioneuroma brought attention to ROHAAD
syndrome as a diagnosis of her situation and helped to
exclude other illnesses that could be considered in the
differential diagnosis. Familial obesity and Prader–Willi
syndrome were both excluded since her family history
did not support the first, and with the absence of mental
retardation and congenital abnormalities there was no
indication to investigate the latter.
A good improvement in consciousness was achieved
by stopping sedative drugs, so she was able to speak,
move her limbs, and interact with others. Nevertheless,
she required prolonged ventilation because of respiratory
instability and she had myoclonic seizures. Three at-
tempts at extubation failed without a clear reason. A
brain MRI was ordered which revealed a generalized
cortical atrophy of her brain with the same mild pituit-
ary gland enlargement observed in a previous MRI
(Fig. 8).
A month after her admission to the ICU, a tracheos-
tomy was performed because of lack of spontaneous
Fig. 6 Chest computed tomography scan showing a mass in the
right lungFig. 5 Chest X-ray reveals a big round opacity in the right lung
Fig. 4 Magnetic resonance imaging. Sagittal and coronal precontrast
T1-weighted image of the patient’s pituitary gland showing normal
anterior and posterior lobes, with homogeneous enlargement and
convex upper surface of the gland
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breathing. One week later, she had cardiorespiratory ar-
rest and died. A timeline of her signs and symptoms is
shown in Fig. 9.
Discussion
ROHHAD is a very rare disease with less than 100 re-
ported cases worldwide to-date [12]. The course and
timing of ROHHAD symptoms are largely variable. Our
patient showed many features of ROHHAD. The symp-
toms appeared as a new course of timing and presenta-
tion. She had a normal healthy childhood for 4 years and
2 months after which she developed a rapid onset of
obesity. At the age of 4.5 years, many symptoms related
to an autonomic dysregulation and a psychiatric disturb-
ance developed without accompanying respiratory or
endocrinal findings.
After only 3 months she developed alveolar
hypoventilation that progressed to severe respiratory dis-
tress and led to mechanical ventilation at our ICU.
Fig. 8 Brain magnetic resonance imaging sections showing generalized brain atrophy
Fig. 7 Microscopic view of the mass tissue stained by hematoxylin
and eosin showing mature elements: ganglion cells (black arrows)
and neurites accompanied by Schwann cells and fibrous tissue (20×)
Aljabban et al. Journal of Medical Case Reports  (2016) 10:328 Page 6 of 9
During the course of her signs and symptoms her pituit-
ary–endocrine axis seemed to be intact and we observed
four neurological findings: a mild enlarged pituitary
gland, a neural crest tumor, generalized brain atrophy,
and myoclonic seizures.
Her pituitary gland measured 7 mm in height and 11
mm in width, with convex upper surface (Fig. 3). These
findings fitted the gland of a teenaged female [13, 14].
Usually, the height of the pituitary gland measures less
than 6 mm in children under the age of 12 years with a
flat or slightly concave upper surface [15, 16]. Premature
puberty was ruled out since no clinical signs nor hormo-
nal findings pointed to it. There is a strong suggestion
that ROHHAD syndrome could share similar pathogen-
etic mechanisms with other immune-mediated central
nervous system disorders, but many aspects remain to
be explained regarding the etiopathogenesis. A paraneo-
plastic etiology has been suggested mainly because of
the frequent association with neural crest tumors, but
recent studies failed to confirm this role [17]. Tumors of
neural crest origin are well known to trigger paraneo-
plastic phenomena, including conditions such as
opsoclonus-myoclonus syndrome [10]. The neural find-
ings in our patient could support the paraneoplastic eti-
ology of ROHHAD with the emphases that she did not
record any episode of hypoxia while under monitoring
Fig. 9 Timeline of signs and symptoms
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in our ICU and that the removal of the tumor did not
improve her situation. It was also postulated that an
autoimmune phenomenon precipitated by specific envir-
onment exposures could underline the etiology of
ROHHAD [18].
The fact that our patient has a first-degree relative
with AML and consanguineous parents brings to mind
the hypothesis of ROHHAD being an epigenetic condi-
tion [10, 19].
LO-CHH used to be confused with ROHHAD because
of the overlapping presentations. Nevertheless, patients
with ROHHAD syndrome express a wide spectrum of
hypothalamic and autonomic abnormalities unlike pa-
tients with LO-CHH [5]. In addition, genetic evaluation
of the LO-CHH-causing mutations in the Paired-like
homeobox 2b (PHOX2B) gene that encodes a transcrip-
tion factor in the autonomic nervous system, established
the distinction between these two clinical disorders [19].
Molecular studies showed that sequencing of the
PHOX2B gene was normal in children with ROHHAD
[8]. Further studies of candidate genes suspected to be
involved in the etiology of ROHHAD based on their role
in the embryologic development of the hypothalamus
and autonomic nerve system [10], or in neuronal devel-
opment [18], failed to define any genetic determinant of
ROHHAD [8]. At the present time, no diagnostic bio-
marker is available to confirm the diagnosis of
ROHHAD which is absolutely based on clinical criteria.
At this stage, the decisive clinical recognition of
ROHHAD could be lifesaving and could prevent the pa-
tient from dramatic consequences due to the severity of
clinical manifestations. ROHHAD syndrome is consid-
ered a life-threatening medical condition with death oc-
curring around the average chronological age of 10 [11].
Of children with ROHHAD, 25% are reported to die be-
cause of respiratory failure [6]. Of patients with
ROHHAD, 50% have obstructive cyanotic episodes
and obstructive sleep apnea followed by symptoms of
abnormal respiratory control before cardiorespiratory
arrest [2].
Conclusions
It was suggested that ROHHAD syndrome should be
considered in all cases of rapid and early-onset obes-
ity associated with hypothalamic pituitary endocrine
dysfunctions [7]. Since the course of clinical presenta-
tions is very variable and unpredictable, and because
endocrinal symptoms may not be found in some pa-
tients like ours, or may develop late after years of
manifested alveolar hypoventilation [9], we suggest
that any rapid gain of weight in an otherwise healthy
child after the age of 2 should be regarded and
treated as ROHHAD syndrome.
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